Noida-based Roto Pumps Ltd has secured an order worth Rs 3.6 crore from Larsen & Toubro Ltd, for Rajasthan Northern Area Development Project of Cairn Energy India Pvt. Ltd.
The company claims that the latest order is the single largest value order in the history of the Roto Pumps, which it has picked amidst stiff International competition.
According to the company, Larsen & Toubro Ltd is the contractor for this project and the project is certified for deemed export benefits.
Gujarat Venture Finance Ltd. (GVFL) has acquired 26.8% stake in Pegasus Semiconductors Pvt. Ltd. for Rs 3.5 crore.
Ahmedabad-based Pegasus offers energy efficient and low cost lighting solutions using LEDs and solar technologies. Among various products of the company, the majority of business comes from 220V LED Street Light System, LED based Solar Home Lighting System and Street Lighting System.
Soft-drinks giant Pepsi would invest $500-million (Rs 2,200 crore) in coming three years. It is disclosed by the CEO and global chairman of PepsiCo. Ms. Indra Nooyi. She was here in Gurgaon (Haryana) to attend the first ever executive committee meeting of company in India. The company has already invested over $1 billion in India.
Though Tata Motors authorities are eagerly awaiting to resume work on the project Nano, they still feel that the situation in Singur has not completely calmed down and it may be risky for them to return.. The information was disclosed by the Chief Minister of West Bengal, Mr Buddhadeb Bhattacharjee.
On Wednesday during a press conference, he announced, “They are closely observing the situation and when they feel the situation is normal they will come back.”
On Tuesday, the CM, talks with its chairman Ratan Tata regarding the issue.
The US Food and Drug Administration have put its report on its website. Some of the products of Indian medicine major, Ranbaxy do not conform to the safety standards set by the inspection agency of US. It has banned 31 drugs produced by Ranbaxy. The agency had not mentioned the name of Daiichi Sankyo, the Japanese firm which is in the process to buy the Indian medicine company in its report